$0.103
+0.0072 (+7.56%)
At Close: Aug 10, 2026
Biotricity (BTCY) Upgraded to Buy: Here's Why
01:01pm, Friday, 15'th Aug 2025
Biotricity (BTCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
REDWOOD CITY, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to redefining the lan
Biotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14th
08:15am, Tuesday, 12'th Aug 2025
Company to announce continued Revenue Growth, Improvements in Margins, Operational Efficiency, and a shift to positive EBITDA
BTCY: CA: A Fun Idea With Yield But Risky
08:33am, Tuesday, 05'th Aug 2025
The Purpose Bitcoin Yield ETF (BTCY:CA) generates income by writing call options on Bitcoin, sacrificing some upside for current yield. This strategy suits investors seeking income from Bitcoin, but n
Biotricity, Inc. (BTCY) Q4 2025 Earnings Conference Call Transcript
09:43pm, Friday, 18'th Jul 2025
Biotricity, Inc. (OTC:BTCY) Q4 2025 Earnings Call July 18, 2025 4:45 PM ET Company Participants S. John Ayanoglou - Chief Financial Officer Waqaas Al-Siddiq - Founder, President, CEO & Chairman Confer
REDWOOD CITY, CA, July 17, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company that offers innovative diagnostic, chronic di
Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th
05:05pm, Tuesday, 15'th Jul 2025
Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an i
REDWOOD CITY, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY) a leading Technology-as-a-Service (Taas) company specializing in cutting-edge diagnostic and chronic disease mana
Biotricity's latest patents focus on a multi-biometric device platform that functions as both a patch and watch, advancing biometric monitoring solutions for remote patient care.
REDWOOD CITY, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY) (“Biotricity” or the “Company”), a top Technology-as-a-Service (TaaS) company that is redefining the hea
Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11%
08:15am, Monday, 17'th Feb 2025
REDWOOD CITY, Calif., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY) (“Biotricity” or the “Company”), a Technology-as-a-Service (TaaS) company operating in the remote cardiac
BTCY:CA - Earn Yield On Your Digital Gold
05:19am, Thursday, 13'th Feb 2025
Purpose Bitcoin Yield ETF offers monthly distributions and long-term capital appreciation through holding Bitcoin and a covered call strategy. The ETF generates a 12.07% yield over a rolling 12-month
Biotricity and B-Secur Partner to Launch the Most Comprehensive Device-Neutral Ambulatory Cardiac Monitoring Platform
10:01am, Wednesday, 15'th Jan 2025
REDWOOD CITY, Calif. and BELFAST, Northern Ireland , Jan. 15, 2025 /PRNewswire/ -- Biotricity Inc. (OTCQB:BTCY), a provider of remote cardiac monitoring solutions, and B-Secur, a leader in biosensin
Biotricity Produces Largest Inventory in its History to Meet Accelerated Demand
08:15am, Friday, 27'th Dec 2024
Company Receives Capital Needed from its Term Lender and Existing Investors to Reach Profitability without any need for future financing. REDWOOD CITY, Calif.
Biotricity Achieves Positive Free Cash Flow Milestone
08:15am, Tuesday, 03'rd Dec 2024
First Time in the Company's History REDWOOD CITY, Calif. , Dec. 3, 2024 /PRNewswire/ -- Biotricity Inc. (OTCQB: BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operati
Sign In
Buy BTCY